Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA.
Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA.
PM R. 2023 Dec;15(12):1519-1523. doi: 10.1002/pmrj.13051. Epub 2023 Sep 13.
Autonomic dysreflexia (AD) is a frequent complication of spinal cord injury (SCI), though current clinical practice patterns for medication management of this condition are unknown. Correspondingly, it is unclear if national differences in practice patterns exist.
To determine trends in current pharmacologic management of AD throughout the Americas.
International survey of current physician practice patterns.
Academic medical center.
Sixty physicians managing patients with SCI and prescribing medications to manage AD.
Not applicable.
Presence of a formal pharmacologic AD management protocol, first- and second-line medications, patient characteristics influencing pharmacologic management.
The majority of physicians (69%) had a formal AD management protocol for inpatient care, with nitroglycerin ointment (82%) being the most common first-line medication. Strong national differences existed regarding the use of nitroglycerin ointment, with 98% of U.S.-based physicians using this as first-line medication and 0% of physicians in Canada or Latin America using this due to recent lack of medication availability. Only 67% of physicians had a preferred second-line medication, with preferences split between hydralazine (48%) and nifedipine (28%). A systolic blood pressure threshold for pharmacologic management was used by 56% of physicians, wheres 26% considered neurological level of injury in decisions to use medications for AD. Heart rate was used by only 5% of physicians in their decision to manage AD with medications.
As of 2023, U.S.-based physicians caring for individuals with SCI largely have formal inpatient protocols in place for medication management of AD, with nearly all relying on nitroglycerin ointment as their first-line medication. In areas outside of the United States where nitroglycerin ointment is unavailable, pharmacologic practice patterns significantly differ.
自主反射障碍(AD)是脊髓损伤(SCI)的常见并发症,尽管目前对此病症的药物管理的临床实践模式尚不清楚。相应地,尚不清楚是否存在实践模式方面的国家差异。
确定整个美洲目前 AD 药物管理的趋势。
对当前医生实践模式的国际调查。
学术医疗中心。
管理 SCI 患者并开具药物以治疗 AD 的 60 名医生。
不适用。
是否存在正式的药物 AD 管理方案,一线和二线药物,影响药物管理的患者特征。
大多数医生(69%)为住院患者制定了正式的 AD 管理方案,硝酸甘油软膏(82%)是最常用的一线药物。关于硝酸甘油软膏的使用存在明显的国家差异,98%的美国医生将其作为一线药物,而加拿大或拉丁美洲的医生由于最近药物供应不足而完全不使用这种药物。只有 67%的医生有首选的二线药物,其中肼屈嗪(48%)和硝苯地平(28%)的选择各占一半。56%的医生使用药物管理 AD 的收缩压阈值,而 26%的医生则根据神经损伤水平决定是否使用药物治疗 AD。只有 5%的医生在决定使用药物治疗 AD 时会考虑心率。
截至 2023 年,护理 SCI 患者的美国医生大多为 AD 的药物管理制定了正式的住院患者方案,几乎所有医生都依赖硝酸甘油软膏作为一线药物。在美国以外的地区,由于无法获得硝酸甘油软膏,药物治疗模式存在显著差异。